J. Goldman & Co LP

Source: SEC Form 13F · as of Mar 2026

J. Goldman & Co LP holds 80 biotech & pharma companies tracked by BioSniper, totaling $416.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

80

Total value held

$416.4M

CompanySharesValue
LLYELI LILLY & Co75,380$69.3M
COGTCogent Biosciences, Inc.847,170$32.6M
ABTABBOTT LABORATORIES289,212$29.7M
IONSIONIS PHARMACEUTICALS INC255,260$19.2M
ARDXARDELYX, INC.3,000,513$18.0M
URGNUroGen Pharma Ltd.988,870$17.8M
GMOptec International, Inc.238,446$17.8M
CAPRCAPRICOR THERAPEUTICS, INC.561,522$17.1M
REGNREGENERON PHARMACEUTICALS, INC.20,268$15.7M
NVONovo Nordisk A/S391,335$14.4M
AMGNAMGEN INC29,900$10.5M
GILDGILEAD SCIENCES, INC.74,912$10.4M
PRAXPraxis Precision Medicines, Inc.29,264$9.4M
VSTMVerastem, Inc.1,680,752$8.9M
PFEPFIZER INC290,456$8.2M
AZNASTRAZENECA PLC40,000$7.9M
CYTKCYTOKINETICS INC79,507$5.2M
VRTXVERTEX PHARMACEUTICALS INC / MA10,000$4.5M
TARAProtara Therapeutics, Inc.856,247$4.5M
ABBVAbbVie Inc.20,000$4.3M
TERNTerns Pharmaceuticals, Inc.80,725$4.3M
LQDALiquidia Corp106,512$4.0M
SNYSanofi75,000$3.6M
IMCRImmunocore Holdings plc114,749$3.5M
BMYBRISTOL MYERS SQUIBB CO50,000$3.0M
DGXQuest Diagnostics Incorporated15,000$2.9M
ABEOABEONA THERAPEUTICS INC.640,530$2.9M
TRVITrevi Therapeutics, Inc.236,959$2.8M
GLUEMonte Rosa Therapeutics, Inc.171,771$2.8M
ALNYALNYLAM PHARMACEUTICALS, INC.8,000$2.6M
ARWRARROWHEAD PHARMACEUTICALS, INC.41,210$2.6M
MLTXMoonLake Immunotherapeutics136,900$2.6M
MLYSMineralys Therapeutics, Inc.94,101$2.5M
DERMJourney Medical Corp500,188$2.3M
PCRXPacira BioSciences, Inc.97,772$2.2M
IMMXImmix Biopharma, Inc.228,089$2.1M
PMPhilip Morris International Inc12,400$2.1M
SLDBSolid Biosciences Inc.284,467$2.0M
EWTXEdgewise Therapeutics, Inc.61,421$1.9M
MRKMerck & Co., Inc.16,000$1.9M
INCYIncyte Corp.20,400$1.9M
RZLTRezolute, Inc.585,892$1.8M
MGTXMeiraGTx Holdings plc206,210$1.8M
ARVNARVINAS, INC.156,799$1.7M
VRDNViridian Therapeutics, Inc.\DE83,098$1.6M
CNTACentessa Pharmaceuticals plc40,500$1.6M
TGTXTG THERAPEUTICS, INC.48,235$1.6M
ERASErasca, Inc.98,033$1.6M
ABVXAbivax SA12,749$1.4M
FBRXForte Biosciences, Inc.54,174$1.4M
REPLReplimune Group, Inc.175,400$1.3M
WVEWave Life Sciences Ltd.175,496$1.3M
ANABANAPTYSBIO, INC21,205$1.2M
ELVNEnliven Therapeutics, Inc.28,662$1.1M
PTHSPelthos Therapeutics Inc.50,415$1.1M
MDGLMADRIGAL PHARMACEUTICALS, INC.2,000$1.0M
PTGXProtagonist Therapeutics, Inc9,714$1.0M
TARSTarsus Pharmaceuticals, Inc.14,541$1.0M
ALKSAlkermes plc.27,100$958K
ANNXAnnexon, Inc.170,817$946K
GERNGERON CORP610,659$910K
INSMINSMED Inc5,545$907K
ZBIOZenas BioPharma, Inc.36,797$719K
JNJJOHNSON & JOHNSON2,900$709K
DNTHDianthus Therapeutics, Inc. /DE/7,716$648K
RLAYRelay Therapeutics, Inc.63,637$633K
LEGNLegend Biotech Corp33,900$613K
IVAInventiva S.A.103,518$575K
ALMSALUMIS INC.23,448$517K
VKTXViking Therapeutics, Inc.15,294$498K
LPCNLipocine Inc.42,170$337K
QUREuniQure N.V.20,300$332K
KODKodiak Sciences Inc.7,610$290K
CPIXCUMBERLAND PHARMACEUTICALS INC81,040$263K
IMTXImmatics N.V.22,788$224K
MDWDMediWound Ltd.13,070$211K
SRPTSarepta Therapeutics, Inc.7,500$163K
LRMRLarimar Therapeutics, Inc.33,756$152K
TSHATaysha Gene Therapies, Inc.33,750$151K
ZVRAZEVRA THERAPEUTICS, INC.13,497$126K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.